Caption Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-10,000
Closed -$673K 1745
2025
Q4
$673K Buy
+10,000
New +$673K ﹤0.01% 1174
2025
Q1
Sell
-50,000
Closed -$2.39M 1728
2024
Q4
$2.39M Buy
+50,000
New +$2.56M 0.02% 629
2022
Q2
Sell
-51,800
Closed -$2.07M 1596
2022
Q1
$2.07M Buy
+51,800
New +$1.85M 0.02% 743
2021
Q3
Sell
-40,000
Closed -$1.82M 1620
2021
Q2
$1.82M Sell
40,000
-21,000
-34% -$929K 0.02% 711
2021
Q1
$2.54M Buy
+61,000
New +$2.78M 0.05% 447
2020
Q2
Sell
-60,000
Closed -$1.08M 1042
2020
Q1
$1.08M Sell
60,000
-85,000
-59% -$1.61M 0.06% 387
2019
Q4
$2.57M Buy
145,000
+75,000
+107% +$1.3M 0.09% 313
2019
Q3
$1.09M Buy
70,000
+40,000
+133% +$659K 0.06% 364
2019
Q2
$516K Buy
+30,000
New +$484K 0.03% 475
2018
Q1
Sell
-535,500
Closed -$10.8M 261
2017
Q4
$10.8M Buy
+535,500
New +$9.84M 1.13% 22

Other funds holding HALO

Caption Management's HALO Position: Q1 2025 in Review

Caption Management sold out of Halozyme (HALO) in Q1 2025, closing a stake of 13,700 shares — an estimated $655K sold.

Caption Management first reported a position in HALO in Q3 2019 and held it in 5 quarters. The position peaked at $1.56M in Q4 2022. 550 funds tracked by Wall St. Rank hold HALO as of Q1 2025.

  • Caption Management reported no remaining Halozyme position as of Q1 2025 after selling out during the quarter.
  • Caption Management sold 13,700 Halozyme shares in Q1 2025, an estimated $655K.
  • Caption Management first reported a position in Halozyme in Q3 2019 and held it in 5 quarters.
  • Caption Management's Halozyme position peaked at $1.56M in Q4 2022.
  • 550 funds tracked by Wall St. Rank held Halozyme as of Q1 2025.

Based on Caption Management's 13F filing for Q1 2025, filed 15 May 2025.